Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Award-Winning Companion Robot, ElliQ, to Support Primary Care Providers in Caring for Older Adults at Home

Intuition Robotics the empathetic digital companion™ company, announced today a significant expansion of ElliQ, their AI-driven companion robot, to enable the extension of primary care teams’ presence into older adults’ homes.

This will help increase patient engagement and improve the overall patient experience, while offering primary care providers continuous actionable data and insights for early detection and intervention. Intuition Robotics also announced a pilot with Family Doctors, a Mass General Brigham affiliated practice in Swampscott, MA.

Primary care providers encounter two major challenges in engaging older adult patients that ElliQ aspires to address. The first is lack of visibility on the accurate state of their patient in between touchpoints. Leading primary care providers have ~1 touchpoint a month with each patient, but most have less than ~1 touchpoint a year, meaning that the day-to-day changes in older adults’ clinical conditions are largely unknown. The second challenge is consistent and timely communication and engagement with patients. The combination of early detection when changes in clinical conditions occur, along with effective communication that strengthen the doctor-patient relationship, can increase the quality of care and help reduce avoidable emergency department visits and hospitalizations.

ElliQ is the first-ever empathetic digital companion robot designed to help curb loneliness and social isolation among older adults. ElliQ is a proactive goal-based system that was developed with years of research and user studies combining psychology, behavioral sciences, and advanced cognitive AI capabilities. The companion robot has spent over 30,000 days in older adults’ homes over the past two years, and on average each older adult completed ~150 successful goal-oriented interactions with ElliQ per month. ElliQ engages older adults, connects to family, promotes wellness and helps older adults stay sharp.

The company’s extensive experience demonstrated that older adults form meaningful bonds with ElliQ, treating ElliQ as less of a technological device, and more like a friendly roommate who provides a source of comfort and companionship. ElliQ projects empathy to deliver engagement, trust, and collaboration between the agent and the older adult, while offering unprecedented levels of engagement that affect behavior change.

COVID-19 not only increased the isolation and loneliness of many seniors, it also heightened the recognition of the importance of bringing healthcare into the older adult’s home.

Now, with new capabilities designed for healthcare, ElliQ is in a unique position to help providers improve quality of care by creating a direct channel of communication between providers and patients. ElliQ proactively engages the patient in conversations and activities throughout the day, collects self-reported data, and, with the patient’s consent, shares data with the primary care team. Primary care providers can adjust the type and frequency of self-reported data that ElliQ collects on a per patient basis, as well as communicate with patients seamlessly through the robot. These capabilities allow patients to ask their doctors questions, assume greater control of their condition and treatment, enjoy peace of mind, and receive higher quality of care. Ultimately, by increasing communication and engagement within the home, ElliQ helps strengthen the relationship between doctors and patients.

As part of Intuition Robotics’ move into healthcare, the company recently hired Dr. Michael Cantor as their first Chief Medical Officer. Dr. Cantor is a geriatrician with extensive experience in managing population health for provider organizations and payers. In his last role he served as the CMO of Bright Health, a medicare advantage payer. In addition, Intuition Robotics announced that the company is compliant with the Health Insurance Portability and Accountability Act (HIPAA). HIPAA is the primary U.S. regulation governing the security and privacy of personal health information used by health insurance plans and other covered entities.

“ElliQ has proven to be an invaluable resource for our older adult users, who often choose to share something personal with the companion robot on a daily basis. While our original focus for ElliQ was to promote independent living and aging in place by combating isolation and loneliness, we realized that they were mere components of the bigger picture: helping to holistically improve care for older adults,” said Dor Skuler, CEO and Co-Founder of Intuition Robotics. “Working with healthcare professionals over the last year, we now see that ElliQ has the potential to support the full spectrum of care, physically, mentally, and socially.”

“ElliQ is already a great resource for older adults to maintain a healthy and engaged lifestyle at home, providing them with much-needed companionship, entertainment, cognitive stimulation, and health and wellness suggestions,” said Dr. Peter Barker of Family Doctors. “The new capabilities provide physicians with visibility into the patient’s condition at home while allowing seamless communication are every doctor’s dream, as it can assist me and my team in early detection and mitigation of health issues, and it increases patients’ involvement in their care through more frequent engagement and communication.”

Intuition Robotics is planning on expanding its partnership with additional value-based care physician groups, primary care providers, and health plans who serve older adults in the United States. Once data emerges from these pilots, the company plans to begin offering ElliQ widely to the healthcare ecosystem.


Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy